miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
about
Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma.MicroRNA-targeted therapeutics for lung cancer treatment.miRNA-200c-3p is crucial in acute respiratory distress syndrome.Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ.ATM Signaling Pathway Is Implicated in the SMYD3-mediated Proliferation and Migration of Gastric Cancer Cells.Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions.GEJ cancers: gastric or esophageal tumors? searching for the answer according to molecular identity.miR-181c protects CsA-induced renal damage and fibrosis through inhibiting EMT.Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling.Akt Protein Kinase, miR-200/miR-182 Expression and Epithelial-Mesenchymal Transition Proteins in Hibernating Ground Squirrels.Epithelial plasticity and metastatic cascade.MicroRNA-203 inhibits tumour growth and metastasis through PDPN.Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasionKIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancerCharacterization of microRNA expression in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620)
P2860
Q38637648-62CD99CF-0C8C-4EC3-A962-0840F40EEF67Q38696753-53F9DB36-2B03-4BBD-A5E7-DCC79E649B8BQ38788923-24FBD08A-1B8B-41B8-A73F-F493E78BAFD9Q39014580-23CE2DD1-B378-4AFE-ACBB-DF276CC45D9DQ40129965-D77A345E-3D49-4E86-8119-B6C87782BF6AQ41701996-A392ECDC-E040-4763-BB3C-92FE4CCEC96EQ42362493-74649903-3741-46E4-A8F4-F39E1D23C374Q47116779-C54DF31B-1A89-47DA-96E7-3FE34EDDD4B2Q47128964-42D575CF-7A9E-4E3C-BCF2-07C31F778B23Q47147581-80815D87-E109-40F9-AC39-DFD895059544Q47701429-E9EE26B3-7C70-47EB-A7C5-51358D9E8624Q47846655-B248C2DB-9941-44FC-B496-1AFF94F2D0AEQ49395543-32F75AD1-BE61-4F71-803F-3A120EDD34AEQ49714352-22FA000C-2C14-46D3-BF27-54456CC386A5Q51753286-141DE87A-2948-4030-AA68-3E98F195B785Q55262931-55A14617-B59C-4082-AB98-55A3FDAADB80Q55309854-FA1CBA7C-988B-47E1-A068-07EEB2BC509EQ57128464-5B6A9DB2-43CA-4EDB-9A83-94B60BD213FCQ58599827-8D9ADEF4-41A1-42AE-8B78-BE617503236EQ58692278-101B69E9-1B19-4AF2-97EB-0C497B71DF49Q58790292-3F6B864E-18F8-4A07-8016-04B0B85BD789
P2860
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
@en
type
label
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
@en
prefLabel
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
@en
P2093
P2860
P1476
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
@en
P2093
Emre Yurdusev
Erol Eyüpoğlu
Merve Mutlu
Özge Saatci
Özgür Şahin
P2860
P2888
P304
P356
10.1007/S00109-016-1420-5
P577
2016-04-20T00:00:00Z
P5875
P6179
1014205087